Results 211 to 220 of about 168,470 (330)

The potential of the microbiome as a target for prevention and treatment of carbapenem-resistant Enterobacteriaceae infections. [PDF]

Front Cell Infect Microbiol
Zhang L, Xu T, Chen W, Chai Y, Wu Y, Du X.   +5 more
europepmc   +1 more source

The Economic Impact of Carbapenem Resistant-Non Lactose Fermenter and Enterobacteriaceae Infections on Hospital Costs in Dr. Soetomo General Academic Hospital Surabaya, Indonesia. [PDF]

Antibiotics (Basel), 2022
Lashari Y, Rochmanti M, Purba AKR, Notobroto HB, Sarassari R, Kuntaman K.   +5 more
europepmc   +1 more source

Incidence of infections due to third generation cephalosporin-resistant Enterobacteriaceae - a prospective multicentre cohort study in six German university hospitals [PDF]

, 2018
Anna M. Rohde, Janine Zweigner, Miriam Wiese‐Posselt, Frank Schwab, Michael Behnke, Axel Kola, Birgit Obermann, Johannes K.‐M. Knobloch, Susanne Feihl, Christiane Querbach, Friedemann Gebhardt, Alexander Mischnik, Vera Ihle, Wiebke Schröder, Sabina Armean, Silke Peter, Evelina Tacconelli, Axel Hamprecht, Harald Seifert, Maria J. G. T. Vehreschild, Winfried V. Kern, Petra Gastmeier, on behalf of the DZIF-ATHOS study group, Michael Buhl, Dirk H. Busch, Simone Eisenbeis, Gesche Först, Federico Foschi, Meyke Gillis, D. Hansen, Georg Häcker, Markus Heim, Martin J. Hug, Klaus Kaier, Fabian Küpper, Georg Langebartels, Andrea Liekweg, Hans‐Peter Lipp, Nayana Märtin, Mathias Nordmann, Andrea Pelzer, Luis-Alberto Peña-Diaz, Jan Rupp, C. Schröder, Katrin Spohn, Michaela Steib–Bauert, Jörg Janne Vehreschild, Ulrich vor dem Esche, S. Wolke   +48 more
openalex   +1 more source

Decoding the Pathophysiology of Autoimmune Diseases—Mechanism, Triggers, and Nanotherapeutics: A Review

Advanced NanoBiomed Research, Volume 6, Issue 4, April 2026.
This review highlights how autoimmune diseases arise from intertwined immunological, genetic, and environmental factors, emphasizing gut microbiota dysbiosis as a pivotal driver. It outlines emerging nanotechnology‐based strategies—such as liposomes, hydrogels, and polymeric nanoparticles—that enhance targeted drug delivery, minimize systemic toxicity,
Md. Meraj Ansari, Yunhui Min, Eun‐Ju Ko, Doyoung Kwon, Rehan Khan, Young‐Ok Son   +5 more
wiley   +1 more source

Predicting carbapenem-resistant Enterobacteriaceae infections in pediatric liver transplant recipients. [PDF]

World J Pediatr
Wang YY, Wang WL, Sun Y, Zhang W, Zhang YT, Gao SL, Wu J, Shen Y, Zhu ZC, Bai XL, Zhang Q, Liang TB.   +11 more
europepmc   +1 more source

Multi‐omics Analysis Reveals the Correlation of Gut Microbiota and Metabolites With Thalidomide Treatment for Chemotherapy‐Induced Nausea and Vomiting in Small Cell Lung Cancer

Biotechnology Journal, Volume 21, Issue 4, April 2026.
Graphical Abstract and Lay Summary We characterize the gut microbiota signatures associated with Thalidomide treatment in small cell lung cancer patients experiencing chemotherapy‐induced nausea and vomiting. The analysis reveals significant changes in specific genera, linking microbial composition to symptom management. ABSTRACT Small cell lung cancer
Qiang‐Guo Sun, Dan Zang, Yu Xin, Jia Cui, Xu Han, Jun Chen   +5 more
wiley   +1 more source

Risk Factors and Prognosis of Polymyxin- and Carbapenem-Resistant Enterobacteriaceae Infections: A Propensity-Matched Real-World Study. [PDF]

Microorganisms
Xu J, Liang M, Luo Y, Qu J.
europepmc   +1 more source

Influence of Gut Microbiota on Response to Immune Check Point Inhibitors in MASLD Patients With HCC: Unraveling the Connection

Cancer Medicine, Volume 15, Issue 4, April 2026.
ABSTRACT Immune checkpoint inhibitors (ICIs) have emerged as a promising treatment for various cancers, including advanced hepatocellular carcinoma (HCC). However, a significant proportion of patients with HCC, particularly those with metabolic dysfunction‐associated liver disease (MASLD), exhibit resistance to ICI therapy.
Mazen Elsheikh, Mohamad Ali Ibrahim, Sherry Fares, Megha Bhongade, Karim Adhem, Ximena I. Ramirez‐Morales, Ahmed O. Kaseb, Joseph Petrosino, Manal M. Hassan, Prasun K. Jalal   +9 more
wiley   +1 more source

Efficacy, Safety, and Cost-Effectiveness Analysis of Ceftazidime-Avibactam versus Polymyxin B in the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections: A Target Trial Emulation. [PDF]

Infect Dis Ther
Hu N, Xiao F, Chen Y, Gu Q, Liang P, Xu Y, Liu J, Liu Y, Li YC, Xu Y, Liu M, Chen D, Zhang H.   +12 more
europepmc   +1 more source

Enterobacteria secrete an inhibitor of Pseudomonas virulence during clinical bacteriuria [PDF]

, 2017
Avignon, D. Andre, Giblin, Daryl E, Henderson, Jeffrey P, Ohlemacher, Shannon I, Stapleton, Ann E, Trautner, Barbara W   +5 more
core   +2 more sources